{
    "2021-06-08": [
        [
            {
                "time": "",
                "original_text": "泰格医药与您相约“BIONNOVA生物医药创新者论坛”",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "BIONNOVA",
                        "生物医药",
                        "创新者论坛"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：159.45万股限制性股票解除限售条件成就",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "限制性股票",
                        "解除限售",
                        "159.45万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：可解除限售的限制性股票共159.4519万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "限制性股票",
                        "解除限售",
                        "159.4519万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)：159.45万股限售股将解禁 解禁",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "限售股",
                        "解禁",
                        "159.45万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股多数调整，恩捷股份、凯莱英、泰格医药、金域医学等跌幅居前",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "恩捷股份",
                        "凯莱英",
                        "泰格医药",
                        "金域医学",
                        "跌幅居前"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "太突然！大赚388.84%，五年期冠军基金又变了",
                "features": {
                    "keywords": [
                        "大赚",
                        "388.84%",
                        "五年期冠军基金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "3个月收获3个IPO，启明创投医疗健康投资：95分投后服务加持，聚焦重大创新",
                "features": {
                    "keywords": [
                        "启明创投",
                        "医疗健康",
                        "IPO",
                        "投后服务",
                        "重大创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "两市百元股数量达159只，科创板股票占38.36%",
                "features": {
                    "keywords": [
                        "百元股",
                        "科创板",
                        "159只",
                        "38.36%"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "科创板"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}